Health Technology · Pharmaceuticals: Major · NSE: JFLLIFE · data 2026-10-09
JFL Life Sciences Limited
Health check: Weak (2.6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹10.25
Market cap
—
P/E
—
P/B
—
ROE
—
ROCE
—
Debt / equity
—
Dividend yield
—
1-year return
-17.3%
52-week high
₹15.4
52-week low
₹8.55
Operating margin
—
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | — |
| Profit growth, 3 years (yearly) | — |
Similar companies
Medicamen Organics Ltd. (MEDIORG) · Medi-Caps Ltd. (MEDICAPQ) · Lasa Supergenerics Ltd. (LASA) · Sunrest Lifescience Limited (SUNREST) · Ortin Global Ltd (ORTINGLOBE)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open JFLLIFE in NSE Scanner →